Australia markets closed

Swedish Orphan Biovitrum AB (B6E.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
24.52-0.24 (-0.97%)
At close: 08:08AM CEST
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
2,493,000
2,409,000
2,638,000
2,679,000
3,245,000
-
Depreciation & amortisation
2,365,000
3,169,000
2,272,000
2,006,000
2,023,000
-
Stock-based compensation
-
-
-
-
114,000
80,000
Change in working capital
-240,000
-1,160,000
-806,000
1,114,000
-441,000
-
Inventory
-
286,000
413,000
-318,000
-1,325,000
-
Other working capital
3,229,000
-473,000
3,099,000
5,100,000
1,074,000
-
Other non-cash items
859,000
1,089,000
652,000
529,000
390,000
-
Net cash provided by operating activities
4,888,000
4,470,000
4,576,000
5,470,000
4,926,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-1,659,000
-4,943,000
-1,477,000
-370,000
-3,852,000
-
Acquisitions, net
-16,961,000
-16,961,000
0
-
0
-12,880,000
Purchases of investments
-
-
-
0
-120,000
0
Sales/maturities of investments
-
-
-
-
-
0
Net cash used for investing activities
-1,659,000
-21,904,000
-1,477,000
-367,000
-3,964,000
-
Net change in cash
-33,000
-422,000
197,000
629,000
-320,000
-
Cash at beginning of period
212,000
1,361,000
1,045,000
404,000
737,000
-
Cash at end of period
179,000
904,000
1,361,000
1,045,000
404,000
-
Free cash flow
Operating cash flow
4,888,000
4,470,000
4,576,000
5,470,000
4,926,000
-
Capital expenditure
-1,659,000
-4,943,000
-1,477,000
-370,000
-3,852,000
-
Free cash flow
3,229,000
-473,000
3,099,000
5,100,000
1,074,000
-